Cofrex

What Cofrex does

Cofrex is a privately held pharmaceutical export services company founded in 2012 and headquartered in Cairo, Egypt, with a regional marketing subsidiary, Cofrex DWC LLC, located in the Dubai South Free Zone. The company provides an integrated six-module service offering covering market study, regulatory affairs (dossier preparation and multi-country product registration), recruitment and training of medical representatives, sales and marketing, business development, and reports and analytics. Cofrex serves pharmaceutical manufacturers seeking to enter francophone West and Central African markets, with named clients including MEPACO-MEDIFOOD, Orchidia Pharmaceutical Industries, Medical Union Pharmaceuticals (MUP), and MinaPharm, alongside European distribution partners Eurimex and Planet.

The company's core operating model is built on exclusive local agent partnerships across 19 African territories, supported by a field force of 107-110+ medical and sales representatives conducting awareness campaigns and sales activities in pharmacies and clinics. Distribution is conducted through a European supply chain network under tripartite contracts between Cofrex, French distributors, and manufacturers. Cofrex reports €15 million in annual turnover and claims 557 products effectively registered and launched across the 19 countries, and holds ISO 9001 quality management certification.

Revenue is generated through professional services on a quote-based pricing model with multi-year contracts; pricing is not publicly disclosed. GTM motion is enterprise field sales targeting pharmaceutical manufacturers in Egypt and Europe seeking African market entry. Technology stack is not publicly disclosed — the company does not articulate proprietary platforms, AI/ML capabilities, APIs, or integrations. Competitive advantage derives from regulatory expertise, exclusive agent relationships, and an established European-African supply chain rather than technology differentiation.

Name

Cofrex

Legal name

Cofrex

Website

https://cofrex-eg.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Cofrex is a Cairo-based pharmaceutical export services company that helps drug manufacturers register and commercialize products across 19 francophone West and Central African countries via regulatory affairs, exclusive local agent networks, and a 110+ medical representative field force.

Ownership category

akta.pro rank

Product category

Pharmaceutical Export Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)

Keywords

• Pharmaceutical export services
• Regulatory affairs services
• Pharmaceutical market entry
• African pharmaceutical distribution
• Medical representative services

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Regulatory Affairs Services: Cofrex provides regulatory affairs services including product registration, dossier preparation, and market entry facilitation for pharmaceutical products across 19 African countries. They follow product files preparation and submission through local agents, proceeding to launch phase once products are approved in at least 4 countries.
2. Marketing and Sales Services: Marketing material preparation, adaptation to African culture and local market requirements, organizing launching events, conducting training sessions for medical representatives, and awareness campaigns in pharmacies and clinics.
3. Business Development Services: Reviewing and optimizing digital brand identity, updating client relationship management tools, developing new approaches to prospecting and sales conversations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Cofrex provides end-to-end pharmaceutical export services that enable drug manufacturers to register, launch, and sell products in 19 francophone West and Central African countries. The offering bundles market study, regulatory affairs, recruitment and training of medical representatives, sales and marketing execution, business development, and reports and analysis, all delivered through an exclusive network of local agents and a European supply chain.

Product overview

Cofrex is a specialized pharmaceutical export services company offering a unified service portfolio focused on helping pharmaceutical companies enter and operate in the francophone West and Central African market. The company provides six integrated service modules: Market Study (territory analysis and product-market fit), Regulatory Affairs (dossier preparation and product registration across multiple countries), Recruitment & Training (medical representative training), Sales & Marketing (marketing material development and product launches), Business Development (digital brand and CRM optimization), and Reports & Analysis (statistical research and insights). Cofrex operates through a network of local agents in each of 19 African countries, supported by a field force of over 107-110 medical and sales representatives, with distribution managed through a reliable European supply chain network. Cofrex DWC LLC specializes in marketing operations based in Dubai.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Study Filters and identifies products based on compatibility with African market needs, gathering accurate territory information through local agents and delivering intensive market research reports using web research, surveys, and analysis. Designed for pharmaceutical manufacturers evaluating entry into francophone African markets.
• Regulatory Affairs Manages dossier preparation and submission for product registration across at least six African countries through local agents, coordinates approval processes, and structures tripartite contracts between Cofrex, French distributors, and manufacturers. Products are launched once approved in at least four countries. Designed for pharmaceutical manufacturers seeking compliant African market entry.
• Recruitment and Training Conducts training sessions for medical representatives and runs awareness campaigns about products in pharmacies, clinics, and other healthcare settings across African territories. Supports pharmaceutical manufacturers in building capable local promotion teams.
• Sales and Marketing Prepares and adapts marketing materials to African culture and local market requirements, organizes product launching events, and runs promotional campaigns in parallel with regulatory and distribution activities. Targeted at pharmaceutical manufacturers seeking in-country promotion across francophone Africa.
• Business Development

Quantifiable outcome

• 557 products registered and launched in 19 countries
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• MEPACO-MEDIFOODcoreChannel Partner/ Reseller/ DistributorArab Company for Pharmaceutical and Medicinal plants - the largest Egyptian company in the field of herbal and medicinal plants. Cofrex partners with MEPACO for distribution of pharmaceutical products in African markets.
• Orchidia Pharmaceutical IndustriescoreChannel Partner/ Reseller/ DistributorOutstanding Egyptian company specialized in the production of pharmaceutical ophthalmic products, ranked number two in the Egyptian ophthalmic market with the highest growth rate. Cofrex assists with African market expansion.
• Medical Union Pharmaceuticals (MUP)coreChannel Partner/ Reseller/ DistributorProvides solutions to global pharmaceutical customers with a wide range of products and services. Success is an outcome of extensive research and development in the pharmaceutical space, enabling movement up the pharmaceutical value chain.
• EurimexcoreChannel Partner/ Reseller/ DistributorEuropean distributor partner for pharmaceutical products in the supply chain network.
• PlanetcoreChannel Partner/ Reseller/ DistributorDistribution partner for pharmaceutical products.
• MinaPharmcoreChannel Partner/ Reseller/ DistributorPharmaceutical manufacturer client and partner for product registration and African market distribution.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• EVA Pharma: Eva Pharma is one of Egypt's largest pharmaceutical manufacturers with a strong focus on African export markets. It operates its own distribution and registration network into Africa, overlapping directly with Cofrex's exporter-manufacturer business.
• Tridem Pharma: Tridem Pharma is a French pharmaceutical company focused exclusively on distributing essential medicines across West and Central Africa. Like Cofrex, it builds Africa-specific regulatory and distribution capabilities and serves francophone African markets.

Regional players

• Ethimed (Bottu/Droguerie Bottu): Ethimed / Droguerie Bottu is a major Tunisian-North African pharmaceutical distributor with cross-border reach into African markets. It serves as a regional peer in pharma wholesale and registration services.
• Adcock Ingram: Adcock Ingram is a leading South African pharmaceutical manufacturer and distributor. It serves many sub-Saharan African markets and intersects with Cofrex's product-flow and regulatory knowledge in southern Africa.

Broad incumbents

• Aspen Pharmacare: Aspen Pharmacare is Africa's largest pharmaceutical manufacturer and distributor with operations across the continent. It competes for pharma distribution and registration flows in the same geographies Cofrex serves, but at much larger scale.
• Cipla: Indian pharmaceutical major Cipla operates significant African distribution and partnerships. It serves many of the same manufacturers and African markets as Cofrex, but as a global player with broader product portfolio.

Others

• PharmAccess / mPedigree: PharmAccess and similar Africa-focused healthcare market-access enablers work alongside pharma distribution into African markets. Cofrex operates in the same ecosystem of bringing quality medicines into francophone Africa.

Emerging players

• Strides Pharma: Strides Pharma is an Indian manufacturer with regulated-market and emerging-markets focus including Africa. It competes in the same generics-and-export-to-Africa space but builds more vertically integrated distribution than Cofrex.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Cofrexeg
• LinkedInlinkedin.com/company/cofrex-egypt-a91726243

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cofrex